Judy Sarungbam

1.2k total citations
29 papers, 697 citations indexed

About

Judy Sarungbam is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Judy Sarungbam has authored 29 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Judy Sarungbam's work include Renal cell carcinoma treatment (10 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Urinary and Genital Oncology Studies (7 papers). Judy Sarungbam is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Urinary and Genital Oncology Studies (7 papers). Judy Sarungbam collaborates with scholars based in United States, India and Canada. Judy Sarungbam's co-authors include Satish K. Tickoo, Hikmat Al‐Ahmadie, A. Ari Hakimi, Chris Sander, Martin L. Miller, Venkatraman Seshan, Yasin Şenbabaoğlu, Nadeem Riaz, William Lee and Ed Reznik and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Judy Sarungbam

25 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judy Sarungbam United States 10 510 272 268 96 62 29 697
Liang Zhu China 15 359 0.7× 193 0.7× 175 0.7× 65 0.7× 129 2.1× 35 602
Steve Smith United States 7 348 0.7× 364 1.3× 172 0.6× 113 1.2× 97 1.6× 11 750
Malte Kölling Switzerland 11 545 1.1× 55 0.2× 458 1.7× 81 0.8× 17 0.3× 14 861
Susanne Rolle Germany 13 226 0.4× 189 0.7× 80 0.3× 61 0.6× 44 0.7× 16 638
Shinji Kurosaka Japan 14 123 0.2× 185 0.7× 61 0.2× 93 1.0× 59 1.0× 29 406
Jiwen Cheng China 12 360 0.7× 181 0.7× 161 0.6× 109 1.1× 152 2.5× 36 668
Yijie Han China 11 371 0.7× 120 0.4× 341 1.3× 62 0.6× 279 4.5× 12 853
Eirini Papadopoulou Greece 13 209 0.4× 144 0.5× 182 0.7× 33 0.3× 211 3.4× 43 535
Chien‐Hsing Lin Taiwan 10 116 0.2× 69 0.3× 96 0.4× 74 0.8× 89 1.4× 21 366
Nasséra Abermil France 10 379 0.7× 50 0.2× 606 2.3× 450 4.7× 63 1.0× 15 950

Countries citing papers authored by Judy Sarungbam

Since Specialization
Citations

This map shows the geographic impact of Judy Sarungbam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Sarungbam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Sarungbam more than expected).

Fields of papers citing papers by Judy Sarungbam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy Sarungbam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Sarungbam. The network helps show where Judy Sarungbam may publish in the future.

Co-authorship network of co-authors of Judy Sarungbam

This figure shows the co-authorship network connecting the top 25 collaborators of Judy Sarungbam. A scholar is included among the top collaborators of Judy Sarungbam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy Sarungbam. Judy Sarungbam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vertosick, Emily, Nicole Benfante, Andrew T. Lenis, et al.. (2025). Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 43(9). 520.e19–520.e28.
2.
3.
Chen, Jie‐Fu, Achim A. Jungbluth, Sirma H. Koutzaki, et al.. (2024). L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma. Modern Pathology. 37(5). 100467–100467. 6 indexed citations
4.
Nezami, Behtash Ghazi, Shakeel Modak, Judy Sarungbam, et al.. (2023). Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations. Pediatric Blood & Cancer. 70(8). e30434–e30434. 2 indexed citations
5.
Chu, Carissa, Jessica Chen, Karissa Whiting, et al.. (2023). MP63-08 CLINICAL AND GENOMIC RISK FEATURES OF HIGH GRADE T1 NON-MUSCLE INVASIVE BLADDER CANCER. The Journal of Urology. 209(Supplement 4).
6.
7.
Ricci, Zina J., et al.. (2022). CT features of acquired cystic kidney disease-associated renal cell carcinoma. Clinical Imaging. 83. 83–86. 7 indexed citations
8.
Gopalan, Anuradha, Hikmat Al‐Ahmadie, Ying‐Bei Chen, et al.. (2022). Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series. Histopathology. 81(2). 246–254. 11 indexed citations
9.
Yang, Chen, Gowtham Jayakumaran, Judy Sarungbam, et al.. (2020). Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma. Modern Pathology. 34(2). 445–456. 20 indexed citations
10.
Sarungbam, Judy, Rohit Mehra, Scott A. Tomlins, et al.. (2019). Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile. Modern Pathology. 32(5). 701–709. 30 indexed citations
11.
Quintero, Orlando, et al.. (2019). Risk factors of laryngeal cryptococcosis: A case report. Medical Mycology Case Reports. 24. 82–85. 12 indexed citations
12.
Herrera, Diego Adrianzen, et al.. (2018). Synchronous Bone Metastasis From Multiple Myeloma and Prostate Adenocarcinoma as Initial Presentation of Coexistent Malignancies. Frontiers in Oncology. 8. 137–137. 2 indexed citations
13.
Bernstein, Ari, Judy Sarungbam, Victoria Chernyak, Lakshmi Rajdev, & Evan Kovac. (2017). Renal vein tumor thrombus from metastatic anal gland adenocarcinoma. Urology Case Reports. 16. 51–53. 1 indexed citations
14.
Reznik, Ed, Martin L. Miller, Yasin Şenbabaoğlu, et al.. (2016). Mitochondrial DNA copy number variation across human cancers. eLife. 5. 376 indexed citations
15.
Sarungbam, Judy, Narasimhan P. Agaram, Sinchun Hwang, et al.. (2016). Symplastic/pseudoanaplastic giant cell tumor of the bone. Skeletal Radiology. 45(7). 929–935. 18 indexed citations
16.
Schüffler, Peter J., et al.. (2016). Mitochondria-based Renal Cell Carcinoma Subtyping: Learning from Deep vs. Flat Feature Representations. 191–208.
17.
Hakimi, A. Ari, Satish K. Tickoo, Anders J. Skanderup, et al.. (2015). TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype. Modern Pathology. 28(6). 845–853. 122 indexed citations
18.
Furqan, Muhammad, Akintunde Akinleye, Judy Sarungbam, et al.. (2014). Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock. Frontiers of Medicine. 8(2). 254–258. 2 indexed citations
19.
Garg, Jalaj, et al.. (2014). Prosthetic Valve Thrombosis. American Journal of Therapeutics. 23(1). e252–e255. 5 indexed citations
20.
Sarungbam, Judy, et al.. (2012). Urate Crystals in Pancreatic Pseudocyst:A Rare Cause of Intestinal Perforation. American Journal of Clinical Pathology. 138(suppl_1). A235–A235. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang Zhu Breakdown of academic impact, for papers by Steve Smith Breakdown of academic impact, for papers by Malte Kölling Breakdown of academic impact, for papers by Susanne Rolle Breakdown of academic impact, for papers by Shinji Kurosaka Breakdown of academic impact, for papers by Jiwen Cheng Breakdown of academic impact, for papers by Yijie Han Breakdown of academic impact, for papers by Eirini Papadopoulou Breakdown of academic impact, for papers by Chien‐Hsing Lin Breakdown of academic impact, for papers by Nasséra Abermil
Rankless by CCL
2026